Increased Serum Bilirubin Level is Related to Good Collateral Development in Patients with Chronic Total Coronary Occlusion

PubMed: 22293798Objective Bilirubin is a bile pigment with potent anti-oxidant properties; in previous studies it has been reported to be negatively associated with coronary artery disease (CAD). Although elevated serum bilirubin concentrations may protect against endothelial dysfunction, it is not clear whether higher serum bilirubin levels (SBLs) in physiological ranges may work in favor of good collateral development in patients with chronic total coronary occlusion (CTO). Methods The study population consisted of patients who underwent coronary angiography with a suspicion of CAD. Patients who had CTO in at least one major coronary artery were included. Coronary angiograms of 179 eligible patients from our database were reanalyzed and 110 of them had good collateral development and 69 had poor collateral development according to the Cohen-Rentrop method. Results Patients with good collateral development had a lower fasting plasma glucose level (FPG) (p= 0.024) and higher SBLs in comparison to patients with poor collateral development (p <0.001). The number of CTO vessels (p=0.013) and left ventricular ejection fraction (EF%) were higher in good collateral group than poor collateral group (p=0.017). In multivariate analysis, FPG negatively (odds ratio [OR]: 0.981, p= 0.003) and SBL (OR for per 0.1-mg/dL increase: 1.832, p <0.001) and the number of CTO vessels (OR: 5.642, p=0.007) were positively related to coronary collateral development. Conclusion This study suggests that higher bilirubin levels within relatively normal ranges were related with favorable coronary collateral growth in patients with CTO. SBL may be responsible for the difference in coronary collateral vessel development among different patients with coronary artery disease. The antiinflammatory and anti-oxidant properties of bilirubin may mediate this effect. © 2012 The Japanese Society of Internal Medicine